COMPARATIVE EFFICACY OF NOVEL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS AS MONOTHERAPY AND IN COMBINATION WITH METHOTREXATE IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INADEQUATE RESPONSE TO TRADITIONAL DMARDS: A NETWORK META-ANALYSIS